The tests are based on the company's ICE COLD PCR technology, which preferentially enriches mutant DNA sequences in an excess of wild-type DNA.
The Munich-based firm will use the funds to bring its Pharos400 laser-based PCR molecular diagnostic platform to market.
A new study has found that an antigen-based rapid diagnostic test for Ebola could be more reliable under certain circumstances than a recently approved RT-PCR assay for the virus.
Money from the private placement will be used for general corporate and working capital purposes, including activities supporting its ICE COLD-PCR technology.
Experts at Vanderbilt discussed future expansion of its PREDICT program, and provided a glimpse at how doctors have responded to genomic information in EMRs.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.